Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Welch

Showing results (401-410 of 422) with videos related to

Pageof 43
Sort By:
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
The Journal of Clinical Investigation|March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionLukas D Wartman, David E Larson, Zhifu Xiang, et al.
Gene Therapy|July 17, 2020
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIALA R Lyon, D Babalis, A C Morley-Smith, et al.
Haematologica|June 6, 2020
Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimensAbhishek Maiti, Caitlin R Rausch, Jorge E Cortes, et al.
Current Oncology (Toronto, Ont.)|June 7, 2012
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancersT Di Valentin, Y Alam, A Ali Alsharm, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Pageof 43

Showing results (401-410 of 422) with videos related to

Sort By:
Pageof 43
The New England Journal of Medicine|September 13, 2018
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J Duncavage, Meagan A Jacoby, Gue Su Chang, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
The Journal of Clinical Investigation|March 26, 2011
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionLukas D Wartman, David E Larson, Zhifu Xiang, et al.
Gene Therapy|July 17, 2020
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIALA R Lyon, D Babalis, A C Morley-Smith, et al.
Haematologica|June 6, 2020
Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimensAbhishek Maiti, Caitlin R Rausch, Jorge E Cortes, et al.
Current Oncology (Toronto, Ont.)|June 7, 2012
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancersT Di Valentin, Y Alam, A Ali Alsharm, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Pageof 43